Maximum quantity allowed is 999
请选择数量
CAS RN: 147098-20-2 | 產品號碼: R0180
Rosuvastatin Calcium
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | R0180 |
純度/分析方法 
|
>95.0%(HPLC)(N) |
| 分子式 / 分子量 | C__4__4H__5__4CaF__2N__6O__1__2S__2 = 1,001.14 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Frozen (<0°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器
|
200MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 147098-20-2 |
| 相關CAS RN
|
287714-41-4 |
| Reaxys-RN | 7740139 |
| PubChem Substance ID | 253661249 |
| Merck Index(14) | 8270 |
| MDL編號 | MFCD04112702 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(with Total Nitrogen) | min. 95.0 % |
| Purity(Chelometric Titration) | min. 90.0 % |
| Specific rotation [a]20/D | -7.0 to -10.0 deg(C=1, CHCL3) |
| NMR | confirm to structure |
性質
| 熔點 | 160 °C |
| 比旋光 [α]D | -8° (C=1,CHCl3) |
| Maximum Wavelength | 243 nm (Phosphate buffer sol.) |
GHS
相關法規
| RTECS # | MJ9675070 |
運輸資料
| HS編碼* | 2935.90-000 |
Application
VSV-G lentivirus vector transduction enhancer
Rosuvastatin enhances VSV-G lentiviral transduction of NK Cells.1)
References
- 1) Rosuvastatin enhances VSV-G lentiviral transduction of NK cells via upregulation of the low-density lipoprotein receptor
Application
Rosuvastatin Calcium: A Strong HMG-Coa Reductase Inhibitor (a Strong Statin)
Rosuvastatin calcium is a 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor (statin). Compared with most other statins, rosuvastatin possesses a greater number of binding interactions with HMG-CoA reductase and exhibits greater potency in inhibiting enzyme activity and cholesterol synthesis in hepatic cells than other statins. Rosuvastatin is relatively hydrophilic, similar in this respect to pravastatin [P1796]. Rosuvastatin has one of the longest terminal half-life of the statins and is only minimally metabolized by the cytochrome P 450 (CYP 450) enzyme system with no significant involvement of the 3A4 (CYP3A4) enzyme.
References
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (a review)
- A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin
- Structural mechanism for statin inhibition of HMG-CoA reductase
- Determination of simvastatin, pravastatin sodium and rosuvastatin calcium in tablet dosage forms by HPTLC
- A new improved RP-HPLC method for assay of rosuvastatin calcium in tablets
考研文獻
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。